Navigation Links
Cepheid Reports Fourth Quarter And Full Year 2012 Results
Date:1/24/2013

ntangible assets and licenses(1,233)(5,372)(1,233)(5,372)  Amortization of purchased intangible assets(332)(347)(1,330)(1,383)Non-GAAP measure of cost of product sales$ 40,523$ 32,470$ 147,765$ 114,401Gross margin on product sales per GAAP52%50%52%54%Gross margin on product sales per Non-GAAP55%58%54%57%Operating expenses$ 43,063$ 41,293$ 176,878$ 146,057  Stock compensation expense(5,756)(4,806)(21,415)(18,084)  Impairment of intangible assets and licenses(328)-(328)-  Amortization of purchased intangible assets(376)(107)(1,452)(429)Non-GAAP measure of operating expenses$ 36,603$ 36,380$ 153,683$ 127,544Income (loss) from operations$   5,058$ (1,393)$ (21,324)$
3,815  Stock compensation expense6,5645,24924,45219,768  Amortization of purchased intangible assets7084542,7821,812  Impairment of intangible assets and licenses1,5615,3721,5615,372  Litigation settlement--15,110-Non-GAAP measure of income from operations$ 13,891$   9,682$   22,581$   30,767Net income (loss)$   5,644$ (1,649)$ (20,043)$
2,627  Stock compensation expense6,5645,24924,45219,768  Amortization of purchased intangible assets7084542,7821,812  Impairment of intangible assets and licenses, net of tax1,2885,3721,2885,372  Litigation settlement--15,110-  Tax benefit related to intercompany IP transaction--(1,815)-Non-GAAP measure of net income$ 14,204$   9,426$   21,774$   29,579Basic net income (loss) per share$
.09$   (0.03)$
(0.30)$
.04  Stock compensation expense0.090.080.370.32  Amortization of purchased intangible assets0.010.010.040.03  Impairment of intangible assets and licenses, net of tax0.020.090.020.08  Litigation settlement--0.23-  Tax benefit related to intercompany IP transaction--(0.03)-Non-GAAP measure of net income per share$
.21$
.15$
.33$
.47Diluted net income (loss) per share$
.08$   (0.03)$
(0.30)$
.04
'/>"/>
SOURCE Cepheid
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Cepheid to Webcast Upcoming Financial Presentations
2. Cepheid Announces Executive Vice President Emerging Markets
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
7. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
8. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
9. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
10. Luminex Corporation Reports First Quarter 2012 Results
11. Hospira Reports First-Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/gbd3bt/stability_testing ... Testing of Pharmaceuticals (London, UK - December 2-3, 2015)" ... this comprehensive two day seminar delegates will: ... are suitable for global arketing - Be able ... samples and facilities - Know how to save ...
(Date:9/3/2015)... MUMBAI, India , Sept. 3, 2015  Cipla, ... to meet the everyday needs of all patients, today ... into definitive agreements to acquire two US-based companies, InvaGen ... subject to certain closing conditions, is valued at $550 ... combined revenue from these transactions is over $200 million ...
(Date:9/3/2015)... With a population of more than 1 ... also its single largest potential market for goods and ... all major world economies in the average rate of ... health expenditures. As an in vitro diagnostics (IVD) market, ... United States, western European countries, and Japan. China represents ...
Breaking Medicine Technology:Stability Testing of Pharmaceuticals: 2 Day Seminar - London, UK - December 2-3, 2015 2Cipla to acquire 100% of generic businesses in US for $550M 2Cipla to acquire 100% of generic businesses in US for $550M 3Cipla to acquire 100% of generic businesses in US for $550M 4Cipla to acquire 100% of generic businesses in US for $550M 5IVD in China 2IVD in China 3IVD in China 4IVD in China 5IVD in China 6IVD in China 7IVD in China 8IVD in China 9IVD in China 10IVD in China 11IVD in China 12IVD in China 13
... SILVER SPRING, Md., May 6, 2011 The U.S. Food ... allow a new group of patients at risk of stroke ... RX Acculink carotid stent. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... neck bring blood to the brain. The blood flow in ...
... BEACH, Calif., May 6, 2011 Yesterday, the ... Novartis drug Afinitor® (everolimus) for the treatment of ... less than five percent of all pancreatic cancer ... aggressive than the more common form of pancreatic ...
Cached Medicine Technology:FDA Expands Approved Use For Carotid Stent 2FDA Expands Approved Use For Carotid Stent 3FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors 2
(Date:9/4/2015)... ... September 04, 2015 , ... Bio-Logic Aqua® Research, ... devices, announced its only mission and research focus: Water Life Science®. In the ... body water evaporation is becoming dangerously accelerated. As a result of the global ...
(Date:9/4/2015)... ... September 04, 2015 , ... The conference program for the ... October 9-10, 2015 at the Diplomat Resort & Spa has been announced and ... researchers at the top of their field and will be presenting sessions such ...
(Date:9/4/2015)... Seattle, Washington (PRWEB) , ... September 04, 2015 ... ... the design and development of its first neighborhood created specifically for adults with ... located in the Phoenix Metro area and feature 30 cottage or “pocket” homes. ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... Benker Residence in South Glastonbury, Connecticut, has been selected for the Residential Award ... significant energy efficiency and resiliency measures. Chosen from a highly competitive field of ...
(Date:9/4/2015)... ... ... Overseer at The House of Yahweh, has written an open letter to Pope Francis that ... States. , Yisrayl lays out what he says is the true meaning of the Pope’s ... the meaning of his own name and describes what bible prophecy says about his own ...
Breaking Medicine News(10 mins):Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:South Glastonbury Home Selected for Award by Connecticut Green Building Council 2Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2
... individual is born in may play a role in determining ... nervous system disorder multiple sclerosis.// ,Results showed people ... while people born in November are at lowest risk. Those ... those with November birthdays. Conversely people born in November were ...
... rise. Worldwide, most children with cancer live in developing ... countries are 80 percent, while most children in developing ... ,Researchers analyzed data from 63 European, population-based cancer ... were recorded for virtually all tumor types in children. ...
... lumpectomy may be safe for breast cancer patients say ... Standard treatment for women with breast cancer usually involves ... surgery , however for most women the length of ... them to choose mastectomy instead of breast conservation. ...
... new study reveals the steps you take to prevent ... dementia. //According to researchers, risk factors like high blood ... vessels in the brain and can cause death of ... medical studies on drugs designed to slow the progression ...
... shows hydrotherapy, or water exercise, may improve strength and mobility ... than age 50 were involved in the study. Patients were ... a week in a swimming pool, the second exercised in ... Both the water and gym programs focused on resistance exercises. ...
... study researchers say the drug clodronate is an effective treatment ... bones. Researchers studied more than 1,000 patients // with breast ... clodronate a day or a placebo for five years. ... cancer spread to their bones. Fifty-one of these patients were ...
Cached Medicine News:
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: